Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
37.52
+0.08 (0.21%)
At close: Apr 10, 2026, 4:00 PM EDT
37.56
+0.04 (0.11%)
After-hours: Apr 10, 2026, 7:59 PM EDT
Novo Nordisk Stock Forecast
Stock Price Forecast
The 4 analysts that cover Novo Nordisk stock have a consensus rating of "Hold" and an average price target of $51, which forecasts a 35.93% increase in the stock price over the next year. The lowest target is $41 and the highest is $70.
Price Target: $51 (+35.93%)
Analyst Consensus: Hold
* Price targets were last updated on Mar 2, 2026.
Analyst Ratings
The average analyst rating for Novo Nordisk stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 3 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 5 | 5 | 6 | 7 | 7 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $63 → $41 | Strong Buy → Hold | Downgrades | $63 → $41 | +9.28% | Mar 2, 2026 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 24, 2026 |
| Argus Research | Argus Research | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 8, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $60 → $54 | Strong Buy | Maintains | $60 → $54 | +43.92% | Nov 28, 2025 |
| BMO Capital | BMO Capital | Hold Maintains $50 → $46 | Hold | Maintains | $50 → $46 | +22.60% | Nov 25, 2025 |
Financial Forecast
Revenue This Year
291.80B
from 309.06B
Decreased by -5.59%
Revenue Next Year
303.11B
from 291.80B
Increased by 3.88%
EPS This Year
21.37
from 23.03
Decreased by -7.20%
EPS Next Year
21.38
from 21.37
Increased by 0.04%
Financial currency is DKK. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 330.5B | 373.4B | |||
| Avg | 291.8B | 303.1B | |||
| Low | 265.1B | 257.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 6.9% | 28.0% | |||
| Avg | -5.6% | 3.9% | |||
| Low | -14.2% | -11.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 26.46 | 26.46 | |||
| Avg | 21.37 | 21.38 | |||
| Low | 17.16 | 16.57 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 14.9% | 23.8% | |||
| Avg | -7.2% | 0.0% | |||
| Low | -25.5% | -22.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.